Clinical trial
Patient-Centered Outcomes of Sacrocolpopexy Versus Uterosacral Ligament Suspension for the Treatment of Uterovaginal Prolapse
NCT05063331 is registered in ClinicalTrials.gov with University Hospitals Cleveland Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Patient-Centered Outcomes of Sacrocolpopexy Versus Uterosacral Ligament Suspension for the Treatment of Uterovaginal Prolapse
- Lead sponsor
- University Hospitals Cleveland Medical Center
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- December 15, 2021
- Completion date
- May 31, 2029
- Enrollment
- 300 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.